GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
4.440
-0.050 (-1.11%)
At close: Dec 20, 2024, 4:00 PM
4.519
+0.079 (1.78%)
After-hours: Dec 20, 2024, 6:33 PM EST
GoodRx Holdings Market Cap
GoodRx Holdings has a market cap or net worth of $1.71 billion as of December 20, 2024. Its market cap has decreased by -29.18% in one year.
Market Cap
1.71B
Enterprise Value
1.83B
1-Year Change
-29.18%
Ranking
Category
Stock Price
$4.44
Market Cap Chart
Since the IPO on September 23, 2020, GoodRx Holdings's market cap has decreased from $12.67B to $1.71B, a decrease of -86.52%. That is a compound annual growth rate of -37.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 1.71B | -37.21% |
| Dec 29, 2023 | 2.72B | 47.38% |
| Dec 30, 2022 | 1.85B | -85.84% |
| Dec 31, 2021 | 13.04B | -17.43% |
| Dec 31, 2020 | 15.79B | 24.57% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Certara | 1.73B |
| Mesoblast | 1.73B |
| Celldex Therapeutics | 1.71B |
| Fortrea Holdings | 1.71B |
| Integra LifeSciences Holdings | 1.70B |
| Dynavax Technologies | 1.69B |
| Neumora Therapeutics | 1.68B |
| Xencor | 1.68B |